BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19893375)

  • 1. Sudden cardiac death and heart failure.
    Thompson BS
    AACN Adv Crit Care; 2009; 20(4):356-65. PubMed ID: 19893375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
    Disertori M; Dallafior D; Marini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
    Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK
    Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone inhibition reduces the risk of sudden cardiac death in patients with heart failure.
    Anand K; Mooss AN; Mohiuddin SM
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):15-9. PubMed ID: 17083069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of sudden cardiac death in patients with heart failure.
    Houmsse M; Franco V; Abraham WT
    Heart Fail Clin; 2011 Apr; 7(2):147-55, vii. PubMed ID: 21439494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden cardiac death: mechanisms, therapies and challenges.
    Winslow RD; Mehta D; Fuster V
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):352-60. PubMed ID: 16265561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death risk stratification in patients with heart failure.
    Lorvidhaya P; Addo K; Chodosh A; Iyer V; Lum J; Buxton AE
    Heart Fail Clin; 2011 Apr; 7(2):157-74, vii. PubMed ID: 21439495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD; Zelenkofske S; McMurray JJ; Finn PV; Velazquez E; Ertl G; Harsanyi A; Rouleau JL; Maggioni A; Kober L; White H; Van de Werf F; Pieper K; Califf RM; Pfeffer MA;
    N Engl J Med; 2005 Jun; 352(25):2581-8. PubMed ID: 15972864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
    Grimm W; Alter P; Maisch B
    Herz; 2004 May; 29(3):348-52. PubMed ID: 15167963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta-adrenergic blocking agents in preventing sudden cardiac death.
    Pitt B
    Circulation; 1992 Jan; 85(1 Suppl):I107-11. PubMed ID: 1345815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
    Elhendy A; Sozzi F; van Domburg RT; Bax JJ; Schinkel AF; Roelandt JR; Poldermans D
    Am J Cardiol; 2005 Aug; 96(4):469-73. PubMed ID: 16098295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk stratification and prevention of sudden death in patients with heart failure].
    Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
    Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.